Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Shares withheld for taxes SVP, CLO, Alkermes, Inc. gave up 1,938 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP, Alks Inc; CFO ALKS gave up 2,076 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP Finance & CAO, Alks Inc. gave up 1,693 shares (to pay taxes)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $19.50 ($1,950,000)
  7. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $19.70 ($394,056)
  8. 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at an average $19.78 ($1,978,445)
  9. 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $19.76 ($395,116)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $21.54 ($2,153,550)
  14. 4 Exercise or conversion SVP, Alks Inc; CFO ALKS acquired 20,000 shares (option exercise)
  15. 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $22.68 ($2,268,220)
  16. 4 Open-market sale Director and CEO, Alkermes plc sold 100,000 shares at $20.18 ($2,017,830)
  17. 4 Exercise or conversion Director acquired 7,000 shares (option exercise)
  18. 4 Shares withheld for taxes SVP, Med Dev/Med Affairs, CMO gave up 368 shares (to pay taxes)
  19. 4 Open-market sale Director and CEO, Alkermes plc sold 110,000 shares at an average $24.88 ($2,736,428)
  20. 4 Derivatives Options or other derivatives

Page 22 of 67 · 1,323 filings